| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.4M | — |
| SG&A Expense | $2.0M | +210.5% |
| Operating Income | -$3.4M | -417.5% |
| Interest Expense | $23K | +0.0% |
| Pre-tax Income | -$3.0M | -124.9% |
| Income Tax | $55K | +0.0% |
| Net Income | -$3.0M | -125.0% |
| EPS (Basic) | -$0.02 | -166.7% |
| EPS (Diluted) | -$0.02 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.8M | -26.0% |
| Current Assets | $8.9M | -25.3% |
| Total Assets | $8.9M | -25.3% |
| Current Liabilities | $665K | -2.0% |
| Total Liabilities | $3.7M | -0.4% |
| Stockholders' Equity | $5.3M | -36.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.7M | -123.0% |
| Financing Cash Flow | -$411K | -328.3% |
| -166.7% |